AP
OM icon

AtonRa Partners’s Outset Medical OM Stock Holding History

AtonRa Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$109K Sell
1,348
-171
-11% -$13.9K 0.22% 122
2023
Q3 		$248K Sell
1,519
-11
-0.7% -$2.6K 0.52% 96
2023
Q2 		$502K Sell
1,530
-263
-15% -$80.2K 0.78% 58
2023
Q1 		$495K Sell
1,793
-252
-12% -$92.5K 0.72% 63
2022
Q4 		$792K Buy
2,045
+146
+8% +$41.2K 1.01% 36
2022
Q3 		$454K Sell
1,899
-282
-13% -$75.5K 0.45% 96
2022
Q2 		$486K Buy
+2,181
New +$938K 0.45% 104

Other funds holding OM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

AtonRa Partners's OM Position: Q4 2023 in Review

AtonRa Partners reduced its Outset Medical (OM) stake by 11% in Q4 2023, selling an estimated $13.9K and leaving 1,348 shares worth $109K. The position accounts for 0.22% of the portfolio, ranked #122.

AtonRa Partners first reported a position in OM in Q2 2022 and has held it in 7 quarters since. The position peaked at $792K in Q4 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • AtonRa Partners held 1,348 shares of Outset Medical worth $109K as of Q4 2023.
  • AtonRa Partners sold 171 Outset Medical shares in Q4 2023, an estimated $13.9K.
  • Outset Medical made up 0.22% of AtonRa Partners's portfolio in Q4 2023, its #122 holding.
  • AtonRa Partners first reported a position in Outset Medical in Q2 2022 and has held it in 7 quarters since.
  • AtonRa Partners's Outset Medical position peaked at $792K in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.